January 23, 2025

Hospice and Palliative Medicine Advisory Committee Meeting Summary | Fall 2024

The Hospice and Palliative Medicine Advisory Committee—which meets twice a year and is responsible for oversight of policy and assessment in the specialty—held its fall meeting on November 22, 2024. The Advisory Committee reviewed updates on ABIM’s work in a number of key areas and discussed other pressing issues in the field. In addition, representatives […]

Specialty Board Meeting Summaries

January 21, 2025

Medical Oncology Board Meeting Summary | Fall 2024

The Medical Oncology Board—which meets twice a year and is responsible for oversight of policy and assessment in the specialty—held its fall meeting on October 24, 2024. The Specialty Board reviewed updates on ABIM’s work in a number of key areas and discussed other pressing issues in the field. In addition, representatives from the American […]

Specialty Board Meeting Summaries

January 17, 2025

Cardiovascular Board Meeting Summary | Fall 2024

The Cardiovascular Board—which meets twice a year and is responsible for oversight of policy and assessment in the specialty—held its fall meeting on October 29, 2024. The Specialty Board reviewed updates on ABIM’s work in a number of key areas and discussed other pressing issues in the field. In addition, representatives from the following organizations […]

Specialty Board Meeting Summaries

January 7, 2025

Sleep Medicine Advisory Committee Meeting Summary | Fall 2024

The Sleep Medicine Advisory Committee—which meets twice a year and is responsible for oversight of policy and assessment in the specialty—held its fall meeting on November 12, 2024. The Advisory Committee reviewed updates on ABIM’s work in a number of key areas and discussed other pressing issues in the field. In addition, representatives from the […]

Specialty Board Meeting Summaries

January 6, 2025

Internal Medicine Board Meeting Summary | Fall 2024

The Internal Medicine Board—which meets twice a year and is responsible for oversight of policy and assessment in the specialty—held its fall meeting on October 22, 2024. The Specialty Board reviewed updates on ABIM’s work in a number of key areas and discussed other pressing issues in the field. In addition, representatives from the following […]

Specialty Board Meeting Summaries

December 20, 2024

New Medical Oncology Longitudinal Knowledge Assessments with a focus on breast cancer and hematologic neoplasms targeted for launch in July 2026

By Suresh G. Nair, MD, Chair Suresh G. Nair, MD, Chair of the ABIM Medical Oncology Board, is Physician-in-Chief of the Lehigh Valley Cancer Institute (LVCI) in Allentown, Pennsylvania, and leads the health network’s academic programs. Dr. Nair is the Medical Director of the LVCI membership in the Memorial Sloan Kettering Cancer Center Alliance and […]

Announcements

December 16, 2024

Meet ABIM Governance: Dr. Christina Lovato

Christina M. Lovato, MD, is an Associate Professor in the Division of Endocrinology at the University of New Mexico (UNM) Health Sciences Center and Sandoval Regional Medical Center, Program Director for the UNM Endocrinology Fellowship Program and Co-Director for the Medical Specialties Clinics at UNM. She practices general endocrinology with a particular focus in the […]

ABIM Governance

December 9, 2024

Meet ABIM Governance: Dr. Andrew Calvin

Andrew Calvin, MD, MPH, is an Associate Professor of Medicine at the Mayo Clinic College of Medicine and Science, Chair of Education at the Mayo Clinic Health System and Medical Director, Accreditation and Compliance, for the Mayo Clinic School of Continuous Professional Development. He is board certified in Internal Medicine and Cardiovascular Disease; he is […]

ABIM Governance

December 4, 2024

Meet ABIM Governance: Dr. Jonathan Marmur

Jonathan D. Marmur, MD, is a Professor of Medicine and Director of the Cardiac Catheterization Laboratory at SUNY Downstate Medical Center in Brooklyn. Dr. Marmur has trained hundreds of physicians and served on the editorial boards of several prominent journals. He holds a patent for the tissue inhibitor of metalloproteinase-1 (TIMP-1) biomarker, which may predict future adverse events […]

ABIM Governance